Absence of behavioral sensitization in healthy human subjects following repeated exposure to ketamine (Q45245241)

11 December 2017

Absence of behavioral sensitization in healthy human subjects following repeated exposure to ketamine (English)

1 reference

human subject research project

11 December 2017

0 references

7

Anissa Abi-Dargham

1 reference

11 December 2017

Aysenil Belger

8

0 references

Ralitza Gueorguieva

object named as

Ralitza Gueorguieva

3

0 references

John Krystal

13

object named as

John H Krystal

1 reference

11 December 2017

Hyun-Sang Cho

1

1 reference

11 December 2017

Deepak C D'Souza

2

1 reference

11 December 2017

Edward B Perry

4

1 reference

11 December 2017

Steven Madonick

5

1 reference

11 December 2017

Laurence P Karper

6

1 reference

11 December 2017

Walid Abi-Saab

9

1 reference

11 December 2017

Deborah Lipschitz

10

1 reference

11 December 2017

Alexandre Bennet

11

1 reference

11 December 2017

John P Seibyl

12

1 reference

11 December 2017

29 January 2005

1 reference

11 December 2017

1 reference

11 December 2017

179

1 reference

11 December 2017

1

1 reference

11 December 2017

136-143

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-004-2066-5

11 December 2017

0 references

cites work

Physical anhedonia, perceptual aberration, and psychosis proneness

1 reference

https://api.crossref.org/works/10.1007%2FS00213-004-2066-5

Illicit use of ketamine in Scotland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-004-2066-5

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-004-2066-5

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-004-2066-5

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-004-2066-5

Incentive-sensitization and addiction

21 January 2018

1 reference

12 December 2020

The schizophrenia ketamine challenge study debate.

1 reference

12 December 2020

Long-term dangers of ketamine anaesthesia

1 reference

12 December 2020

Four years' treatment with ketamine and a trial of dextromethorphan in a patient with severe post-herpetic neuralgia

1 reference

12 December 2020

Chlorpromazine vs. meperidine in the treatment of phencyclidine psychosis.

1 reference

12 December 2020

Symptom provocation studies in psychiatric disorders: scientific value, risks, and future

1 reference

12 December 2020

Study of potency, kinetics of block and toxicity of NMDA receptor antagonists using fura-2.

1 reference

12 December 2020

Patterns of use and harms associated with non-medical ketamine use.

1 reference

12 December 2020

NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders

1 reference

12 December 2020

1 reference

12 December 2020

Effect of MS-153 on the development of behavioral sensitization to locomotion- and ataxia-inducing effects of phencyclidine

1 reference

12 December 2020

Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia.

1 reference

12 December 2020

Comparison of isomers of ketamine on catalepsy in the rat and electrical activity of the brain and behavior in the cat.

1 reference

12 December 2020

Acute and chronic behavioral interactions between phencyclidine (PCP) and amphetamine: evidence for a dopaminergic role in some PCP-induced behaviors

1 reference

12 December 2020

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

1 reference

12 December 2020

Lack of evidence for context-dependent cocaine-induced sensitization in humans: preliminary studies.

1 reference

12 December 2020

Lack of enhanced response to repeated d-amphetamine challenge in first-episode psychosis: implications for a sensitization model of psychosis in humans

1 reference

12 December 2020

Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis.

1 reference

12 December 2020

The NMDA antagonist model for schizophrenia: promise and pitfalls.

1 reference

12 December 2020

m-Chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients. Evidence implicating serotonergic systems in the positive symptoms of schizophrenia

1 reference

12 December 2020

Pharmacological characterization of locomotor sensitization induced by chronic phencyclidine administration.

1 reference

12 December 2020

Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects

1 reference

12 December 2020

The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants

1 reference

12 December 2020

The ontogeny of behavioral sensitization to phencyclidine

1 reference

12 December 2020

Ketamine: an update on the first twenty-five years of clinical experience

1 reference

12 December 2020

Ketamine: a review of its pharmacologic properties and use in ambulatory anesthesia

1 reference

12 December 2020

Effects of repeated treatment with amphetamine or phencyclidine on working memory in the rat.

1 reference

12 December 2020

Interactive effects of subanesthetic ketamine and haloperidol in healthy humans.

1 reference

12 December 2020

Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine.

1 reference

12 December 2020

Scale for the assessment of reality testing: reliability, validity, and factorial invariance.

1 reference

12 December 2020

The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies

1 reference

12 December 2020

The anticonvulsant and behavioral effects of phencyclidine and ketamine following chronic treatment in rats.

1 reference

12 December 2020

Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia.

1 reference

12 December 2020

Rating scales in research: the case of negative symptoms

1 reference

12 December 2020

Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers

1 reference

12 December 2020

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

1 reference

12 December 2020

Study of a new schizophrenomimetic drug; sernyl.

1 reference

12 December 2020

Psychobiology of the acute stress response and its relationship to the psychobiology of post-traumatic stress disorder

1 reference

12 December 2020

Reserpine and phencyclidine-associated psychosis: three case reports.

1 reference

12 December 2020

Ketamine--its pharmacology and therapeutic uses.

1 reference

12 December 2020

Ketamine in chronic pain management: an evidence-based review

1 reference

12 December 2020

Ketamine tolerance and hallucinations in children

1 reference

12 December 2020

Putatively psychosis-prone subjects 10 years later

1 reference

12 December 2020

The efficacy of ECT in phencyclidine-induced psychosis

1 reference

12 December 2020

1 reference

12 December 2020

Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans.

1 reference

12 December 2020

The behavioral pharmacology of NMDA receptor antagonists

1 reference

12 December 2020

Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS)

1 reference

12 December 2020

Human response to repeated low-dose d-amphetamine: evidence for behavioral enhancement and tolerance

1 reference

12 December 2020

Chronic phenycyclidine (PCP) abuse: a psychiatric perspective--Part II: Psychosis [proceedings]

1 reference

12 December 2020

Animal models of mania.

1 reference

12 December 2020

Comparison of the pharmacologic effects of N-allylnormetazocine and phencyclidine: sensitization, cross-sensitization, and opioid antagonist activity

1 reference

12 December 2020

Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine.

1 reference

12 December 2020

Long-term outcome of patients who receive ketamine during research

1 reference

12 December 2020

Clinical processes and central dopaminergic activity in psychotic disorders

1 reference

12 December 2020

Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity

1 reference

12 December 2020

Phencyclidine-induced behavioral sensitization

1 reference

12 December 2020

Tolerance and sensitization to the behavioral effects of drugs.

1 reference

12 December 2020

The effects of a sub-anaesthetic dose of ketamine on human selective attention.

1 reference

12 December 2020

Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.

1 reference

12 December 2020

A role for sensitization in craving and relapse in cocaine addiction

1 reference

12 December 2020

Development of tolerance to ketamine in an infant undergoing repeated anesthesia.

1 reference

12 December 2020

10.1007/S00213-004-2066-5

Identifiers

DOI

1 reference

Dimensions Publication ID

11 December 2017

0 references

1 reference